Navigation Links
Clinical Lab Products Magazine Features Biomoda
Date:9/2/2008

ALBUQUERQUE, N.M., Sept. 2 /PRNewswire-FirstCall/ -- Clinical Lab Products magazine features Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com) and its proprietary early lung cancer screening assay as one of the more promising advances in the cancer diagnostic technology. The August national magazine article (http://www.clpmag.com/issues/articles/2008-08_01.asp) makes particular note of the assay's simplicity that leads to large scale screening of lung cancer using automated equipment.

"The ease in use of the assay is apparent, as well as the benefit of a test that detects cancer at its earliest stage," said John Cousins, President of Biomoda. Cancer caught at earlier stages is essential for improved outcomes.

Biomoda's patented technology is designed for early lung cancer screening of large populations at a reasonable cost. The non-invasive test, originally developed at Los Alamos National Laboratory, allows clinicians to identify cancerous or aberrant cells extracted from samples of lung sputum; cancerous cells in the sputum exposed to the assay glow red under fluorescent light and can be detected under a microscope.

Earlier this year, Biomoda and the New Mexico Institute of Mining and Technology announced their partnership with the New Mexico Department of Veterans Services to conduct a two-phase study of the state's veterans. The initial phase will screen 225 veterans; a second phase will test more than 2000 veterans for lung cancer using Biomoda's non-invasive patented assay.

Lung cancer claims more lives than any other cancer. The expected five-year survival rate for all patients diagnosed with lung cancer is 15%; the five-year survival rate for cases detected when the disease is still localized is 50 percent. Presently, only 16% of lung cancer cases are diagnosed at this early sta
'/>"/>

SOURCE Biomoda, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
2. Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
3. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
4. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
5. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
6. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
7. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
8. Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
9. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
10. ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrigs Disease
11. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... PITTSBURGH, Dec. 16 Cohera Medical Inc. ... in a study of its lead surgical adhesive ... major milestone in the company,s progression of the ... clinical investigation is a prospective, open-label, randomized study ... effect on wound drainage and associated complications in ...
(Date:12/16/2009)... BOTHELL, Wash., Dec. 16 Verathon®, ... pleased to announce that portable bladder volume ... 2009 CDC guidelines for the Prevention of ... new CDC guidelines, introduced in early November ... back to 1981. The guidelines are ...
(Date:12/16/2009)... Siemens Healthcare today announced a series ... to help healthcare providers pursue meaningful ... the HITECH provision of the American Recovery ... zero-percent interest terms for qualified customers, the ... associated with their technology investment while meeting ...
Breaking Medicine Technology:First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 2New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 4New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 5Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 2Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 3Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use 4Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 1Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 2Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 3Whole Foods Market 28R 29 Partners With Non GMO Project to Label Companys Private Label Food Products Using New Third Party Standard 50904 4Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 1Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 2Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 3Premier Research Launches Oracle 28R 29 Remote Data Capture Onsite 4 5 3 50898 1Premier Research Launches Oracle 28R 29 Remote Data Capture Onsite 4 5 3 50898 2
(Date:12/17/2009)... in Human Resource Development Degree Online , ... ... enrollment has begun for Villanova’s newly online HR master’s ... busy schedules can’t accommodate a campus-based program. With the university’s ... March 2010, location is no longer a barrier to the ...
(Date:12/17/2009)... 17 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... privately negotiated transaction to sell an aggregate of 4,784,689 ... Venrock at a price of $2.09 per share, raising ... Neurocrine expects the financing to close on or about ... ,, A shelf registration statement relating to the ...
(Date:12/17/2009)... Efficient Mechanism to Pursue Approval in Multiple ... /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... initiated the regulatory approval process for its ... Decentralized Procedure (DCP). The DCP provides an ... simultaneously pursue regulatory approval for a medicinal ...
(Date:12/17/2009)... -- Abaxis, Inc. (Nasdaq: ABAX ), a ... and rapid tests for the medical, research and ... the production animal diagnostics marketplace with its first ... is a USDA-licensed test for Avian Influenza Type ... The disposable, non-instrumented device, providing results in 15 ...
(Date:12/17/2009)... elder care expert announces the release of her new book “Priceless ... is a contributing author and the primary compiler of stories for ... Now released in paperback, Priceless Caregiving can be ordered through ... ... St. Louis, MO (PRWEB) December 17, 2009 -- Valerie VanBooven RN ...
Breaking Medicine News(10 mins):Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 2Health News:A World-Class HR Master's Degree Is Now Within Reach – 100% Online 3Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 2Health News:Neurocrine Announces Sale of 4,784,689 Shares of Common Stock, to Raise Proceeds of $10 Million 3Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 2Health News:Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe 3Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 2Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 3Health News:ABAXIS(R) Announces Exclusive Worldwide OEM Agreement for a Lateral Flow Avian Influenza Antigen Test Kit 4Health News:Valerie VanBooven RN BSN Announces the Release of her 3rd Book Celebrating Caregivers and Families 2Health News:Valerie VanBooven RN BSN Announces the Release of her 3rd Book Celebrating Caregivers and Families 3
... Calif., June 16 "Nearly 500,000,Americans die of ... way as the,unfortunate and untimely passing of Mr. ... Lepor, of Westside Medical Associates of Los,Angeles. He ... abnormal heart,rhythm, ventricular tachycardia/fibrillation or asystole. These are ...
... chilhood overweight and higher readings , , MONDAY, June ... pressure in childhood are also prone to hypertension as ... conducted over four decades in different countries. , ... from childhood to adulthood and that elevated blood pressure ...
... Two years ago researchers at the University of Pennsylvania ... accumulated in the motor areas of the brains of ... disease. Now, the same group has shown that TDP-43 ... effects than previously appreciated and treatments need to take ...
... Jose, CA, June 11, 2008 ... the International Nursing Association for Clinical Simulation and ... Clinical Simulation in Nursing ( www.nursingsimulation.org ) beginning ... only journal provides information about the development and ...
... where, but calls it ,most fruitful, lead in ongoing ... News) -- Although a U.S. government investigation into ... for the contamination, health officials said Monday they are ... nine cases in one location. , "The cluster ...
... Mike,Leavitt today declared a public health emergency in ... gives HHS, Centers for Medicare &,Medicaid Services, (CMS) ... in meeting emergency health needs., "The flooding ... individual and,to their communities," Secretary Leavitt said. "This ...
Other Medicine News:Health News:Tim Russert's Sudden Cardiac Death May Have Been Preventable 2Health News:High Blood Pressure in Kids Tracks Into Adulthood 2Health News:Lou Gehrig's protein found throughout brain, suggesting effects beyond motor neurons 2Health News:INACSL and Elsevier partner to publish Clinical Simulation in Nursing 2Health News:FDA Narrowing Tainted Tomato Probe to One Cluster 2Health News:FDA Narrowing Tainted Tomato Probe to One Cluster 3Health News:HHS Takes Action to Help Medicare Beneficiaries and Providers in Iowa and Indiana 2Health News:HHS Takes Action to Help Medicare Beneficiaries and Providers in Iowa and Indiana 3
... catheter design and ergonomic handle for ... radiopaque Nitinol markers on the proximal ... enhance visibility. Corrugated ring design provides ... nested ring pattern minimizes stent shortening, ...
... comprise the world's broadest line of ... Their advanced catheter design and materials ... with a soft, atraumatic tip. Available ... Supreme and Response catheters provide outstanding ...
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety....
Novus 3000 A fully-integrated and powerful 532 nm Operating Room Photocoagulator with reliable DPSS technology and simplified operation using a touch screen interface and remote control....
Medicine Products: